IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform
Article excerpt
Highlighted: the sentence this signal was extracted from
IQVIA announces strategic collaboration with AWS, naming AWS as Preferred Agentic Cloud Provider to power next-generation AI platform. RESEARCH TRIANGLE PARK, N.C.-(BUSINESS WIRE)- IQVIA (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced a strategic collaboration with Amazon Web Services (AWS), naming AWS as IQVIA's Preferred Agentic Cloud Provider. The partnership, revealed at AWS re:Invent, is a major step in the digital transformation of healthcare and life sciences, aiming to revolutionize clinical trial automation, medical affairs and analytics through an innovative agentic AI platform. Under the agreement, IQVIA will deploy its AI platform on AWS to enhance scalable, secure and intelligent automation across clinical trial execution, medical affairs and healthcare analytics. This collaboration is designed to improve clinical trial automation and accelerate trial processes. In addition, IQVIA and AWS will explore new opportunities in life science analytics to drive the next generation of data-driven insights and solutions. With 90% of the world's largest pharmaceutical companies relying on both IQVIA and AWS to power their digital transformation and analytics, the companies are committed to democratizing AI for life sciences, accelerating...
Keep reading with a free account
The rest of this article, and every signal for IQVIA, is in your free account.